1-15 of 15
Arvind Dasari
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 6408: Early carcinoembryonic antigen (CEA) dynamics to predict the efficacy of fruquintinib (F) + best supportive care (BSC) in patients with metastatic colorectal cancer (mCRC) enrolled in FRESCO-2

Sara Lonardi, Arvind Dasari, Rocio Garcia-Carbonero, Takayuki Yoshino, Pilar García-Alfonso, Judit Kocsis, Chiara Cremolini, François Ghiringhelli, Ardaman Shergill, Howard S Hochster, Michel Ducreux, Dirk Arnold, Varsha Sundaresan, Siddha Kasar, Adela Pina, Ziji Yu, William R Schelman, Lucy Chen, Josep Tabernero
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 6408.
https://doi.org/10.1158/1538-7445.AM2024-6408
Published: 22 March 2024
View article titled, Abstract 6408: Early carcinoembryonic antigen (CEA) dynamics to predict the efficacy of fruquintinib (F) + best supportive care (BSC) in patients with metastatic colorectal cancer (mCRC) enrolled in FRESCO-2
Journal Articles

Abstract 1290: Racial and ethnic representation and disparities on clinical guideline panels in oncology

Jonathan M. Loree, Arvind Dasari, Mena Shaheed, Himanish Gothwal, Kulwinder Singh, Hewad Shaheed, Riya Mangal, Shivek Gothwal, Jason Willis, Michael J. Overman, Scott Kopetz, Kanwal Pratap Singh Raghav
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 1290.
https://doi.org/10.1158/1538-7445.AM2024-1290
Published: 22 March 2024
View article titled, Abstract 1290: Racial and ethnic representation and disparities on clinical guideline panels in oncology
Journal Articles

Abstract CT118: A phase I/II trial of a CXCR1/2 inhibitor in combination with anti-PD-1 for circulating tumor DNA (ctDNA) positive & refractoryRAS-mutated microsatellite stable (MSS) colorectal cancer

Benny Johnson, Cara Haymaker, Van K. Morris, Arvind Dasari, Victoria Serpas Higbie, John Paul Shen, Christine Parseghian, Maria Pia Morelli, Ryan Huey, Michael S. Lee, Jason Willis, Kanwal P. Raghav, Ying Yuan, John Zebala, Ronald A. DePinho, Scott Kopetz, Michael Overman
Journal: Cancer Research
Cancer Res (2023) 83 (8_Supplement): CT118.
https://doi.org/10.1158/1538-7445.AM2023-CT118
Published: 14 April 2023
View article titled, Abstract CT118: A phase I/II trial of a CXCR1/2 inhibitor in combination with anti-PD-1 for circulating tumor DNA (ctDNA) positive &amp; refractory<em>RAS-</em>mutated microsatellite stable (MSS) colorectal cancer
Journal Articles

Abstract CT218: A phase II trial of niraparib plus dostarlimab in relapsed small cell lung cancer and other high-grade neuroendocrine carcinomas

Carl M. Gay, C. Allison Stewart, Michael Frumovitz, Junya Fujimoto, Yuann xi, Qi Wang, Runsheng Wang, Veronica Novegil, Mehmet Altan, Tina Cascone, Arvind Dasari, Yasir Y. Elamin, Frank V. Fossella, Bonnie S. Glisson, Charles S. Lu, Marcelo V. Negrao, Ferdinandos Skoulidis, Natalie Vokes, Robert J. Cardnell, Ignacio I. Wistuba, Jing Wang, John V. Heymach, Lauren A. Byers
Journal: Cancer Research
Cancer Res (2023) 83 (8_Supplement): CT218.
https://doi.org/10.1158/1538-7445.AM2023-CT218
Published: 14 April 2023
View article titled, Abstract CT218: A phase II trial of niraparib plus dostarlimab in relapsed small cell lung cancer and other high-grade neuroendocrine carcinomas
Journal Articles

Abstract B028: Changes in exosomal RNA expression associate with treatment response to BRAF + EGFR + PD-1 blockade in MSS, BRAFV600E colorectal cancer: A liquid biopsy approach

Van Karlyle Morris, Kimal I. Rajapakshe, Vahid Bahrambeigi, Christine M. Parsehgian, Benny Johnson, Kanwal P. Raghav, Arvind Dasari, Ryan W. Huey, Michael J. Overman, Jason Willis, Michael S. Lee, Robert A. Wolff, Bryan K. Kee, Phat Le, Paola A. Guerrero, Scott Kopetz, Anirban Maitra
Journal: Cancer Research
Cancer Res (2022) 82 (23_Supplement_1): B028.
https://doi.org/10.1158/1538-7445.CRC22-B028
Published: 01 December 2022
View article titled, Abstract B028: Changes in exosomal RNA expression associate with treatment response to BRAF + EGFR + PD-1 blockade in MSS, BRAF<sup>V600E</sup> colorectal cancer: A liquid biopsy approach
Journal Articles

Abstract PR005: Outcomes in colitis-associated metastatic colorectal cancer and intersection with early-onset and signet ring cell carcinoma

Oscar E. Villarreal, Fadl Zeineddine, Ray Chacko, Christine Parseghian, Benny Johnson, Jason Willis, Michael Lee, Van Karlyle Morris, Arvind Dasari, Kanwal Raghav, Michael Overman, Y. Nancy You, Yinghong Wang, Dipen Maru, John Paul Shen, Scott Kopetz
Journal: Cancer Research
Cancer Res (2022) 82 (23_Supplement_1): PR005.
https://doi.org/10.1158/1538-7445.CRC22-PR005
Published: 01 December 2022
View article titled, Abstract PR005: Outcomes in colitis-associated metastatic colorectal cancer and intersection with early-onset and signet ring cell carcinoma
Journal Articles

Abstract A023: Influence of pre-diagnosis obesity and post-diagnosis aspirin use on survival from stage IV colorectal cancer

Jennifer S. Davis, Janelle C. Chavez, Melissa Kok, Yazmin San Miguel, Hwa Young Lee, Henry Henderson, Michael J. Overman, Van Karlyle Morris, Bryan Kee, David Fogelman, Shailesh M. Advani, Benny Johnson, Christine Parseghian, John Paul Shen, Arvind Dasari, Kenna R. Shaw, Eduardo Vilar, Kanwal P. Raghav, Imad Shureiqi, Robert A. Wolff, Funda Meric-Bernstam, Dipen Maru, David G. Menter, Scott Kopetz, Shine Chang
Journal: Cancer Research
Cancer Res (2022) 82 (23_Supplement_1): A023.
https://doi.org/10.1158/1538-7445.CRC22-A023
Published: 01 December 2022
View article titled, Abstract A023: Influence of pre-diagnosis obesity and post-diagnosis aspirin use on survival from stage IV colorectal cancer
Journal Articles

Abstract 4344: Racial representativeness of cancer clinical trials sponsored by the National Cancer Institute compared to pharmaceutical companies

Joseph M. Unger, Dawn L. Hershman, Raymond U. Osarogiagbon, Anirudh Gothwal, Seerat Anand, Arvind Dasari, Michael Overnman, Jonathan M. Loree, Kanwal Raghav
Journal: Cancer Research
Cancer Res (2020) 80 (16_Supplement): 4344.
https://doi.org/10.1158/1538-7445.AM2020-4344
Published: 15 August 2020
View article titled, Abstract 4344: Racial representativeness of cancer clinical trials sponsored by the National Cancer Institute compared to pharmaceutical companies
Journal Articles

Abstract 4576: Study of the immune contexture in advanced pancreatic neuroendocrine tumors reveals tumor-associated macrophages as promoters of poor survival

Alejandro Francisco-Cruz, Naohiro Uraoka, Suyu Liu, Edwin R. Parra, Luisa M. Solis, Barbara Mino, Arvind Dasari, Jaime Rodriguez-Canales, Michael J. Overman, Jonathan M. Loree, James C. Yao, Ignacio I. Wistuba, Daniel M. Halperin, Jeannelyn S. Estrella
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): 4576.
https://doi.org/10.1158/1538-7445.AM2019-4576
Published: 01 July 2019
View article titled, Abstract 4576: Study of the immune contexture in advanced pancreatic neuroendocrine tumors reveals tumor-associated macrophages as promoters of poor survival
Journal Articles

Phase Ib Results of the Rational Combination of Selumetinib and Cyclosporin A in Advanced Solid Tumors with an Expansion Cohort in Metastatic Colorectal Cancer

Anuradha Krishnamurthy, Arvind Dasari, Anne M. Noonan, Janice M. Mehnert, Albert C. Lockhart, Stephen Leong, Anna Capasso, Mark N. Stein, Hanna K. Sanoff, James J. Lee, Aaron Hansen, Usha Malhotra, Sarah Rippke, Daniel L. Gustafson, Todd M. Pitts, Kim Ellison, S. Lindsey Davis, Wells A. Messersmith, S. Gail Eckhardt, Christopher H. Lieu
Journal: Cancer Research
Cancer Res (2018) 78 (18): 5398–5407.
https://doi.org/10.1158/0008-5472.CAN-18-0316
Published: 14 September 2018
View article titled, Phase Ib Results of the Rational Combination of Selumetinib and Cyclosporin A in Advanced Solid Tumors with an Expansion Cohort in Metastatic Colorectal Cancer
Open the PDF for Phase Ib Results of the Rational Combination of Selumetinib and Cyclosporin A in Advanced Solid Tumors with an Expansion Cohort in Metastatic Colorectal Cancer in another window
Journal Articles

Abstract 4742: APCWT/RASWT/BRAFWT tumors represent an under recognized poor prognostic group of right sided colorectal cancer

Jonathan M. Loree, Krittiya K. Korphaisarn, Michael Lam, Van K. Morris, Kanwal P. Raghav, Michael J. Overman, Cathy Eng, Arvind Dasari, Bryan K. Kee, David Fogelman, Robert A. Wolff, Kenna Shaw, Russell Broaddus, Mark J. Routbort, Rajyalakshmi Luthra, Dipen M. Maru, David G. Menter, Funda Meric-Bernstam, Scott Kopetz
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): 4742.
https://doi.org/10.1158/1538-7445.AM2017-4742
Published: 01 July 2017
View article titled, Abstract 4742: <em>APC</em><em><sup>WT</sup></em><em>/RAS</em><em><sup>WT</sup></em><em>/BRAF</em><em><sup>WT</sup></em> tumors represent an under recognized poor prognostic group of right sided colorectal cancer
Journal Articles

Abstract CT146: A phase IB study of the combination of AZD6244 hydrogen sulfate (selumetinib) and cyclosporin A (CsA) in patients with advanced solid tumors with an expansion cohort in metastatic colorectal cancer (mCRC)

Anna Capasso, Arvind Dasari, A. Craig Lockhart, Mark Stein, Hanna Sanoff, James Lee, Aaron Hansen, Tanios Bekaii-Saab, Sarah Rippke, James Yao, Funda Meric-Bernstam, S Gail Eckhardt, Christopher h. Lieu
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): CT146.
https://doi.org/10.1158/1538-7445.AM2016-CT146
Published: 15 July 2016
View article titled, Abstract CT146: A phase IB study of the combination of AZD6244 hydrogen sulfate (selumetinib) and cyclosporin A (CsA) in patients with advanced solid tumors with an expansion cohort in metastatic colorectal cancer (mCRC)
Journal Articles

Abstract 5190: Biomarkers of sensitivity to PF-03084014, a γ-secretase Inhibitor, in a preclinical model of colorectal cancer

Rebecca W. Powell, Aik Choon Tan, Marileila Varella-Garcia, Basel Touban, Arvind Dasari, Lauren Puls, Todd Pitts, Gillian Kulikowski, Kevin Quackenbush, Wells Messersmith, John J. Arcaroli
Journal: Cancer Research
Cancer Res (2011) 71 (8_Supplement): 5190.
https://doi.org/10.1158/1538-7445.AM2011-5190
Published: 15 April 2011
View article titled, Abstract 5190: Biomarkers of sensitivity to PF-03084014, a γ-secretase Inhibitor, in a preclinical model of colorectal cancer
Journal Articles

Abstract 5050: Biomarkers for sensitivity to gamma secretase inhibitors in mouse models of pancreatic adenocarcinoma

Arvind Dasari, Rebecca W. Powell, Lauren Puls, Kevin Quackenbush, Aik Choon Tan, Wells Messersmith, John Boylan, John Arcaroli
Journal: Cancer Research
Cancer Res (2011) 71 (8_Supplement): 5050.
https://doi.org/10.1158/1538-7445.AM2011-5050
Published: 15 April 2011
View article titled, Abstract 5050: Biomarkers for sensitivity to gamma secretase inhibitors in mouse models of pancreatic adenocarcinoma
Journal Articles

Oxidative Stress Induces Premature Senescence by Stimulating Caveolin-1 Gene Transcription through p38 Mitogen-Activated Protein Kinase/Sp1–Mediated Activation of Two GC-Rich Promoter Elements

Arvind Dasari, Janine N. Bartholomew, Daniela Volonte, Ferruccio Galbiati
Journal: Cancer Research
Cancer Res (2006) 66 (22): 10805–10814.
https://doi.org/10.1158/0008-5472.CAN-06-1236
Published: 15 November 2006
View article titled, Oxidative Stress Induces Premature Senescence by Stimulating Caveolin-1 Gene Transcription through p38 Mitogen-Activated Protein Kinase/Sp1–Mediated Activation of Two GC-Rich Promoter Elements
Open the PDF for Oxidative Stress Induces Premature Senescence by Stimulating Caveolin-1 Gene Transcription through p38 Mitogen-Activated Protein Kinase/Sp1–Mediated Activation of Two GC-Rich Promoter Elements in another window
Includes: Supplementary data